Skip to main content

Prevention and Screening Innovation Project Towards Elimination of Cervical Cancer

Objective

The proposed Prevention and Screening Innovation Project towards Elimination of Cervical Cancer (PRESCRIP-TEC) will lead to effective and innovative cervical cancer screening, including direct treatment and follow-up for women in resource-poor or hard-to-reach settings in the world, by improving availability, accessibility, acceptability and quality of services. PRESCRIP-TEC will conduct implementation research into cervical cancer screening and secondary prevention in different settings in four countries over three continents: Bangladesh and India in Asia, Uganda in Africa, and Slovakia in Eastern Europe. We will analyse patient- and health services-related facilitators and barriers for uptake of cervical cancer screening in low- and middle-income countries and in vulnerable groups in Eastern Europe. By taking existing screening protocols in the four countries, we will introduce 1) interactive information with communities via mobile devices and social media; 2) client-friendly, community-based strategies, with self-test for high risk HPV infection; and 3) artificial intelligence in gynaecological examination. The use of artificial intelligence built into mobile devices offers a future for high quality diagnostics in resource-poor settings. By doing so, we will reduce the number of physical examinations and implement screenings by lower-level trained cadres. In addition, through a cost-effectiveness analysis and a business case for the global introduction of hrHPV testing as routine screening for cervical cancer, we will show the advantage of point-of-delivery testing and the benefits of self-testing for cancer in the post-COVID era, which reduces pressure on the health system. PRESCRIP-TEC will strengthen evidence of innovative strategies for cervical cancer screening as advocated by the World Health Organization and will contribute to eradication of cervical cancer worldwide through prevention and early diagnosis, alleviating the global burden of cancer.

Call for proposal

H2020-SC1-2020-Single-Stage-RTD
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

ACADEMISCH ZIEKENHUIS GRONINGEN
Address
Hanzeplein 1
9713 GZ Groningen
Netherlands
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 569 000

Participants (10)

FEMALE CANCER FOUNDATION
Netherlands
EU contribution
€ 656 750
Address
Albinusdreef 2
2333 ZA Leiden
Activity type
Other
TRNAVSKA UNIVERZITA V TRNAVE
Slovakia
EU contribution
€ 703 750
Address
Hornopotocna 23
918 43 Trnava
Activity type
Higher or Secondary Education Establishments
ZDRAVE REGIONY
Slovakia
EU contribution
€ 72 250
Address
Limbova 3330/2
837 52 Bratislava
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
LIGA PROTI RAKOVINE SLOVENSKEJ REPUBLIKY
Slovakia
EU contribution
€ 29 000
Address
Brestova 4/6
821 02 Bratislava
Activity type
Other
CONNAXIS SERVICIOS DE MARKETING SL
Spain
EU contribution
€ 222 500
Address
Calle Maestro Arbos 9 Piso Bj Pta 1
28045 Madrid
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
THE UNIVERSITY OF EDINBURGH
United Kingdom
EU contribution
€ 47 500
Address
Old College, South Bridge
EH8 9YL Edinburgh
Activity type
Higher or Secondary Education Establishments
INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH BANGLADESH
Bangladesh
EU contribution
€ 135 750
Address
Shaheed Tajuddin Ahmed Sharani 68
1212 Dhaka
Activity type
Research Organisations
FRIENDSHIP
Bangladesh
EU contribution
€ 239 375
Address
K14/2a Baridhara North Road Kalachandpur Main Road Gulshan
1212 Dhaka
Activity type
Other
UGANDA RURAL DEVELOPMENT AND TRAINING PROGRAMME
Uganda
EU contribution
€ 243 437,50
Address
Kagadi
Kampala
Activity type
Other
UGANDA CANCER INSTITUTE
Uganda
EU contribution
€ 79 000
Address
Upper Mulago Hill Road
Kampala
Activity type
Research Organisations